Open AccessOX40 Agonism Enhances Efficacy of PD-L1 Checkpoint Blockade by Shifting the Cytotoxic T Cell Differentiation Spectrum
Author(s) -
Guillaume Beyrend,
Tetje C. van der Sluis,
Esmé T.I. van der Gracht,
Tamim Abdelaal,
Simon P. Jochems,
Robert A. Belderbos,
Thomas Wesselink,
Suzanne van Duikeren,
Floortje van Haften,
Anke Redeker,
Elham Beyranvand Nejad,
Marcel Camps,
Kees L. M. C. Franken,
Margot M. Linssen,
Peter Hohenstein,
Noel F.C.C. de Miranda,
Hailiang Mei,
Adriaan D. Bins,
J. Haanen,
Joachim G.J.V. Aerts,
Ferry Ossendorp,
Ramon Arens
Publication year - 2022
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.4035850
Subject(s) - cancer immunotherapy , cytotoxic t cell , cancer research , cd8 , immune checkpoint , immunotherapy , chemokine , immune system , chemokine receptor , t cell , immunology , biology , in vitro , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom